Trastuzumab infusion reactions in breast cancer. Should we routinely observe after the first dose?
{{output}}
Trastuzumab (Herceptin) is used in neoadjuvant, adjuvant and metastatic breast cancer. Infusion reactions are a common side effect most of which are mild and easily managed, anaphylaxis occurs rarely. The summary of product characteristics recommends observati... ...
